PharmExec Direct eNewsletter

PharmExec Direct:
Having trouble viewing this e-mail? Click here.

You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile

PharmExec Direct | From the editors of Pharmaceutical Executive

December 15, 2011 | ISSUE NUMBER 230 VOL 8

Big Pharma
The Curious Case of Graceway Pharmaceuticals
Graceway Pharmaceuticals took a late-stage product bought from 3M and turned it into a mini-franchise. Despite a Chapter 11 bankruptcy, Medicis acquired the company for $455 million three weeks ago. The model was celebrated at a conference last week ...Read More

Leadership
Putting the M Back in M&A
Joe Panetta, president and CEO of BIOCOM, talks about an emerging model of M&As in which biotech brings expertise to Big Pharma as venture capitalist funding dwindles and patent cliffs loom large ...Read More

Regulatory
Is HHS Using Scientific Standards?
Just when it seemed that controversy over the Plan B contraceptive was a thing of the past, the drug returned to the headlines when HHS Secretary Kathleen Sebelius overruled FDA’s decision to allow Teva’s Plan B One-Step to be sold over the counter to girls under the age of 17 ...Read More

Global
KOL Networks: What's New?
Marc Pesse proposes five powerful ideas for managing key opinion leader networks ...Read more

Ad Stars 2012
Call For Entries
It’s that time again for the editors of Pharm Exec to narrow down its choices for our annual Ad Stars feature, recognizing the most clever, unique, and effective campaigns in pharma advertising over the past year. We’d like to extend an opportunity for you to submit an ad for consideration. Please feel free to share with us the campaign that your firm or agency feels truly helps the client stand apart from its competition ...For more info

// Pfizer President and CEO Ian Reade has been elected as the company's Chairman of the Board. // Eli Lilly elected Katherine Baicker, Professor of Health Economics at the Harvard School of Public Health, to its Board of Directors. // Takeda appointed Dr. Rajeev Venkayya as leader of its new vaccines division, to be opened next month. // Biocartis (Lausanne, Switzerland) has appointed Dr. Nayan Gregory Parekh as its new Chief Executive Officer. Rudi Pauwels, co-founder of Biocartis and current CEO, will become Executive Chairman.

Jan. 24–25: CBI's 9^th Annual Compliance Congress
Washington, DC

Feb. 16–17: Pharma Strategy and Business Innovation Conference
Cancun, Mexico

Feb. 28–29: Global Transparency Congress
London, UK

	Follow Pharm Exec on Twitter
	Follow Pharm Exec on Facebook

Which of the following has been most significant in influencing a change in your business strategy in 2011?

Competitive threats
Regulation
The economy
Shareholder expectations
Customer demand

Don't Fear the Cloud!

'Nearsourcing' Explained

35 Years of Pharmaceutical Technology Magazine

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.